IDEAYA Biosciences Now Covered by Analysts at Stephens

IDYA Stock  USD 26.54  0.25  0.93%   
About 66% of Ideaya Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Ideaya Biosciences suggests that many traders are alarmed. The current market sentiment, together with Ideaya Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Ideaya Biosciences stock news signals to limit their universe of possible portfolio assets.
  
Stephens started coverage on shares of IDEAYA Biosciences in a research note issued to investors on Monday, MarketBeat.com reports. The firm issued an overweight rating and a 51.00 price objective on the stock. Several other research firms also recently commented on IDYA. Leerink Partnrs downgraded shares of IDEAYA Biosciences from a

Read at thelincolnianonline.com
news
  

Ideaya Biosciences Current Investor Sentiment

Panic Vs Confidence

34

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Ideaya Biosciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Ideaya Biosciences.

Ideaya Biosciences Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Ideaya Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Ideaya Biosciences Historical Investor Sentiment

Investor biases related to Ideaya Biosciences' public news can be used to forecast risks associated with an investment in Ideaya. The trend in average sentiment can be used to explain how an investor holding Ideaya can time the market purely based on public headlines and social activities around Ideaya Biosciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ideaya Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ideaya Biosciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Ideaya Biosciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Ideaya Biosciences.

Ideaya Biosciences Fundamental Analysis

We analyze Ideaya Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ideaya Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ideaya Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Ratio

Current Ratio Comparative Analysis

Ideaya Biosciences is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Ideaya Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ideaya Biosciences stock to make a market-neutral strategy. Peer analysis of Ideaya Biosciences could also be used in its relative valuation, which is a method of valuing Ideaya Biosciences by comparing valuation metrics with similar companies.

Peers

Ideaya Biosciences Related Equities

VTYXVentyx Biosciences   11.35   
0%
100.0%
ANABAnaptysBio   8.22   
0%
72.0%
AMLXAmylyx Pharmaceuticals   7.40   
0%
65.0%
MGTXMeiraGTx Holdings   6.75   
0%
59.0%
RNAAvidity Biosciences   4.35   
0%
38.0%
SNDXSyndax Pharmaceuticals   3.98   
0%
35.0%
VRNAVerona Pharma   2.24   
0%
19.0%
TERNTerns Pharmaceuticals   1.40   
0%
12.0%
RVMDRevolution Medicines   1.32   
0%
11.0%
KROSKeros Therapeutics   1.18   
0%
10.0%
SWTXSpringWorks Therapeutics   0.95   
0%
8.0%
MLTXMoonLake Immunotherapeuti   0.28   
2.0%
0%
ABOSAcumen Pharmaceuticals   0.42   
3.0%
0%
PTGXProtagonist Therapeutics   2.00   
17.0%
0%
DAWNDay One   2.19   
19.0%
0%
INZYInozyme Pharma   6.05   
53.0%
0%
XFORX4 Pharmaceuticals   8.11   
71.0%
0%

Complementary Tools for Ideaya Stock analysis

When running Ideaya Biosciences' price analysis, check to measure Ideaya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ideaya Biosciences is operating at the current time. Most of Ideaya Biosciences' value examination focuses on studying past and present price action to predict the probability of Ideaya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ideaya Biosciences' price. Additionally, you may evaluate how the addition of Ideaya Biosciences to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
CEOs Directory
Screen CEOs from public companies around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities